spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Heavy Menstrual Bleeding 

 HSMN NewsFeed - 27 Oct 2025
Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Jul 2020
Channel Medsystems(R) Receives FDA Approval of its Latest Cerene(R) Cryotherapy Device for the Treatment of Heavy Menstrual Bleeding in the Office Setting
Devices FDA
 HSMN NewsFeed - 5 Aug 2019
AbbVie Submits New Drug Application to US FDA for Investigational Elagolix for Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Women
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Apr 2018
Women Treated with Hologic's NovaSure(R) Endometrial Ablation System in New Study Reported Higher Amenorrhea Rates than Those Treated with Minerva
Devices Interventional
 HSMN NewsFeed - 10 Oct 2017
Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Aug 2017
Channel Medsystems(R) Secures $14.1mm Financing for Office-Based Treatment of Heavy Menstrual Bleeding
Devices Venture Capital
 HSMN NewsFeed - 26 Jun 2017
Channel Medsystems(R) Earns CE Mark Approval for the Cerene(R) Cryotherapy Device
Devices Regulatory
 HSMN NewsFeed - 25 Jan 2017
Myovant Sciences Initiates Phase 3 Clinical Program of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Biopharmaceuticals
 HSMN NewsFeed - 17 Jan 2017
Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids
Biopharmaceuticals
 HSMN NewsFeed - 16 Nov 2016
Myovant Sciences Appoints Terrie Curran to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Aug 2015
Channel Medsystems Secures $22 Million Series C Financing Led by Third Point Ventures
Devices Venture Capital
 HSMN NewsFeed - 4 Aug 2015
Gynesonics Announces New CPT Code Established for Sonata(TM) System
Devices Reimbursement
 HSMN NewsFeed - 25 Jul 2013
The Fibroid Treatment Collaborative Adopts Acessa(TM) Procedure as First Line Surgical Therapy for Uterine Fibroids
Devices Surgery
 HSMN NewsFeed - 20 Feb 2013
Gynesonics Completes $21 Million Series D Financing
Devices Venture Capital
 HSMN NewsFeed - 7 Jan 2011
Hologic Acquires Interlace Medical
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 6 Jan 2011
Gynesonics Receives the CE-Mark for the VizAblate(TM) System to Treat Uterine Fibroids
Devices Regulatory
 HSMN NewsFeed - 16 Jun 2010
Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis
Biopharmaceuticals
 HSMN NewsFeed - 27 May 2010
Xanodyne Announces Planned President & CEO Succession
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2010
Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 18 Dec 2009
Ligand Announces Positive Regulatory Opinion in Europe for Revolade for Chronic Immune Thrombocytopenic Purpura
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Jun 2009
Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 2 Apr 2009
Xanodyne's New Drug Application for the Treatment of Heavy Menstrual Bleeding (Menorrhagia) Accepted for Filing with a Priority Review Classification
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Aug 2008
Xanodyne Achieves Positive Efficacy Results in Pivotal Phase 3 Studies of Proprietary Modified Release Oral Tranexamic Acid Product Candidate for Heavy Menstrual Bleeding
Biopharmaceuticals
 HSMN NewsFeed - 20 Jan 2008
CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
Devices Interventional
 HSMN NewsFeed - 30 Jan 2007
Cytyc Announces New UK NICE Clinical Guideline Recommends Endometrial Ablation Instead of Hysterectomy For Most Women with Heavy Menstrual Bleeding
Devices
 HSMN NewsFeed - 10 Nov 2006
Study Reports GYNECARE THERMACHOICE III Helps Most Women With Heavy Periods Return to Normal or Less Bleeding
Devices
 HSMN NewsFeed - 9 May 2006
ETHICON, Inc. Completes Acquisition of Vascular Control Systems, Inc.
Devices Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 8

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 8 additional stories matching:
Heavy Menstrual Bleeding
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!